CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China flag China · Delayed Price · Currency is CNY
6.42
-0.27 (-4.04%)
Aug 24, 2026, 3:04 PM CST

SHE:000908 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,43075.685.5213.17181.39172.18
Cash & Short-Term Investments
1,65375.685.5213.17181.39172.18
Cash Growth
6352.38%-11.61%549.63%-92.74%5.35%4.86%
Accounts Receivable
79.9561.5970.1385.92197.02217.24
Other Receivables
76.6186.0315.3331.9527.1691.22
Receivables
156.55147.6285.46117.86224.18308.46
Inventory
51.1938.8344.1864.58120.37155.4
Other Current Assets
20.1513.312.0318.1545.3541.48
Total Current Assets
1,881275.35227.19213.76571.3677.51
Property, Plant & Equipment
318.02316.27328.67434.21553.48726.1
Long-Term Investments
51.6651.29210.9444.7250.46103.86
Goodwill
--0.120.1233.0333.03
Other Intangible Assets
60.5364.1853.4561.55101.66100.47
Long-Term Deferred Tax Assets
3.264.292.4910.4130.323.57
Long-Term Deferred Charges
102.3198.41111.12107.86106.49117.4
Other Long-Term Assets
19.1610.156.01187.7210.8210.36
Total Assets
2,436819.95939.981,0601,4581,792

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
59.31107.92102.96148.94138.54122.97
Accrued Expenses
5.9646.4853.45105.76109.5163.29
Short-Term Debt
-9.76191.67195.82213.02475.67
Current Portion of Long-Term Debt
1.3776.18260.9299.42299.8387.68
Current Portion of Leases
-1.4911.463.673.631.3
Current Income Taxes Payable
23.6910.462.460.624.931.17
Current Unearned Revenue
10.4215.6916.2824.1926.225.22
Other Current Liabilities
272.85533.57265.56263.12287.71283.8
Total Current Liabilities
373.59801.56904.731,0421,0831,361
Long-Term Debt
---72.2872.521
Long-Term Leases
5.435.886.7122.699.847.87
Long-Term Unearned Revenue
11.7913.5817.1520.7324.8151.01
Long-Term Deferred Tax Liabilities
00.842.917.76.455.27
Other Long-Term Liabilities
13.1126.3523.6170.0458.9338.34
Total Liabilities
403.92848.2955.111,2351,2561,465

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,296416.69416.69416.69416.69416.69
Additional Paid-In Capital
1,843639.91617.75617.75617.75617.42
Retained Earnings
-1,009-1,015-933.99-1,086-850.2-708.89
Comprehensive Income & Other
-18.45-18.57-18.65-18.59-19.46-18.83
Total Common Equity
2,08923.1481.8-70.45164.79306.39
Minority Interest
-57.15-51.39-96.93-104.1936.8521.34
Shareholders' Equity
2,032-28.25-15.13-174.64201.63327.73
Total Liabilities & Equity
2,436819.95939.981,0601,4581,792

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
6.893.32470.74593.88598.81873.52
Net Cash (Debt)
1,647-17.72-385.22-580.72-417.42-701.35
Net Cash Growth
------
Net Cash Per Share
1.45-0.02-0.44-0.66-0.47-0.80
Filing Date Shares Outstanding
1,9211,760879.77879.77879.77879.77
Total Common Shares Outstanding
1,921879.77879.77879.77879.77879.77
Working Capital
1,508-526.2-677.54-827.79-512.06-683.57
Book Value Per Share
1.090.030.09-0.080.190.35
Tangible Book Value
2,029-41.0428.23-132.1230.1172.89
Tangible Book Value Per Share
1.06-0.050.03-0.150.030.20
Buildings
-267.57267.57337.65401.86527.56
Machinery
-267.36280.5291.5412.21385.78
Construction In Progress
-72.9970.2270.2288.3787.72